Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
13 Settembre 2016 - 11:16PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION
OF REGISTRATION UNDER SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934.
Commission File Number: 001-33514
Transition
Therapeutics Inc.
(Exact name of registrant as specified
in its charter)
101
College Street, Suite 220
Toronto, Ontario, Canada M5G 1L7
(416) 260-7770
(Address, including zip code, and telephone
number, including area code, of registrant's principal executive offices)
Common
Shares, no par value
(Title of each class of securities
covered by this Form)
None
(Titles of all other classes of securities
for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in
the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)
S
|
Rule 12g-4(a)(2)
£
|
Rule 12h-3(b)(1)(i)
S
|
Rule 12h-3(b)(1)(ii)
£
|
Rule 15d-6
£
|
Approximate number
of holders of record as of the certification or notice date:
1
Pursuant to the requirements
of the Securities Exchange Act of 1934, Transition Therapeutics Inc. has caused this certification/notice to be signed on its behalf
by the undersigned duly authorized person.
|
|
Date: September 13, 2016
|
By:
|
/s/ Nicole Rusaw
|
|
|
Nicole
Rusaw
Chief Financial Officer
|
Grafico Azioni Transition Therapeutics - Ordinary Shares (NASDAQ:TTHI)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Transition Therapeutics - Ordinary Shares (NASDAQ:TTHI)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Transition Therapeutics - Ordinary Shares (NASDAQ): 0 articoli recenti
Più Transition Therapeutics Inc. Articoli Notizie